These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27088514)

  • 1. Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths.
    Caloro M; Calabrò G; Kotzalidis GD; Cuomo I; Corkery JM; Vento AE; Lionetto L; De Filippis S; Ranieri V; Lonati D; Locatelli CA; de Pisa E; Di Tommaso A; Girardi P; Schifano F
    Addict Behav; 2016 Sep; 60():53-7. PubMed ID: 27088514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia.
    Bae K; Kwon NJ; Han E
    Forensic Sci Int; 2018 Nov; 292():45-49. PubMed ID: 30273913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids].
    Kekelidze ZI; Klimenko TV; Kozlov AA; Shakhova SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):21-26. PubMed ID: 29376979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland.
    Liakoni E; Dolder PC; Rentsch K; Liechti ME
    Swiss Med Wkly; 2015; 145():w14166. PubMed ID: 26218967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance abuse and psychosis. The strange case of opioids.
    Maremmani AG; Rovai L; Rugani F; Bacciardi S; Dell'Osso L; Maremmani I
    Eur Rev Med Pharmacol Sci; 2014; 18(3):287-302. PubMed ID: 24563427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
    Tanibuchi Y; Matsumoto T; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2013; 115(5):463-76. PubMed ID: 23855225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome in cycloserine-induced psychosis.
    Sawant NS; Kate NS; Bhatankar SS; Kulkarni PS
    Indian J Pharmacol; 2015; 47(3):328-9. PubMed ID: 26069374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment-resistant psychosis due to interaction between ritonavir and olanzapine: case report and literature review].
    van Oeffelt T; Prinsen EJ
    Tijdschr Psychiatr; 2016; 58(4):309-13. PubMed ID: 27075223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
    Fattore L
    Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department.
    Bogstrand ST; Normann PT; Rossow I; Larsen M; Mørland J; Ekeberg Ø
    Drug Alcohol Depend; 2011 Sep; 117(2-3):132-8. PubMed ID: 21316163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
    Tucker MG; Kekulawala S; Kent M; Mostafa S; Harvey R
    J Med Case Rep; 2016 Sep; 10(1):242. PubMed ID: 27599617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.
    Beck O; Franzén L; Bäckberg M; Signell P; Helander A
    Clin Toxicol (Phila); 2016 Aug; 54(7):568-75. PubMed ID: 27412885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute Psychosis after Consumption of Synthetic Cannabinoids].
    Mörkl S; Blesl C; Wurm WE; Tmava A
    Fortschr Neurol Psychiatr; 2016 Mar; 84(3):150-4. PubMed ID: 27029042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
    Skryabin VY; Vinnikova MA
    J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Catatonia de novo, report on a case: immediate vital prognosis and psychiatric prognosis in longer term].
    Patry L; Guillem E; Pontonnier F; Ferreri M
    Encephale; 2003; 29(1):72-9. PubMed ID: 12640330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suicidal and homicidal behaviors related to dextromethorphan abuse in a middle-aged woman.
    Modi D; Bhalavat R; Patterson JC
    J Addict Med; 2013; 7(2):143-4. PubMed ID: 23388679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.